Comparative Analysis of Renal Function Outcomes Following Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: A Systematic Review and Meta-analysis
Authors:
- Rafaela Hamada JucaRJRafaela Hamada Juca
- Pedro Bicudo BregionPBPedro Bicudo Bregion
- Josélio Rodrigues de Oliveira-FilhoJOJosélio Rodrigues de Oliveira-Filho
- Giulia Almiron da Rocha SoaresGSGiulia Almiron da Rocha Soares
- Sofia Hamada JucaSJSofia Hamada Juca
- Victor Kenzo IvanoVIVictor Kenzo Ivano
- Everton CazzoECEverton Cazzo
- 8 January 2025
- journal article
- research article
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (2) , 587-601
Abstract
Background Obesity is a significant risk factor for chronic kidney disease (CKD), with metabolic bariatric surgery offering potential renal benefits. However, there is limited comparative data on the impact of Roux-en-Y gastric bypass (RYGB) versus laparoscopic sleeve gastrectomy (LSG) on renal function in individuals with obesity without end-stage renal disease (ESRD). The objective of this study was to compare renal function outcomes following RYGB and LSG in patients with obesity, focusing on estimated glomerular filtration rate (eGFR), serum creatinine, albumin-creatinine ratio (ACR), and serum cystatin C. Methods A systematic review and meta-analysis were conducted following Cochrane and PRISMA guidelines. Data from 17 observational studies (n = 3339) were analyzed. Primary outcomes included changes in eGFR, ACR, serum creatinine, and cystatin C. Secondary outcomes included excess weight loss (%EWL) and total weight loss (%TWL). Statistical analysis involved fixed and random-effects models based on heterogeneity levels. Results RYGB demonstrated significant improvements in eGFR (SMD = − 0.71; 95% CI − 0.89 to − 0.52, p < 0.00001) and serum cystatin C (MD = − 0.10; 95% CI − 0.17 to − 0.03, p = 0.004) compared to LSG. No significant differences were found for serum creatinine (MD = − 1.06; 95% CI − 4.42 to 2.30, p = 0.54) or ACR (MD = 1.95; 95% CI − 0.39 to 4.29, p = 0.10). RYGB also showed greater long-term weight loss, particularly at 5 years (%EWL: MD = 22.00; 95% CI 6.56 to 37.44, p = 0.005). Conclusions RYGB offers similar renal improvements with superior weight loss compared to LSG in individuals with obesity without ESRD. These findings emphasize the need for personalized treatment approaches and further research to validate these outcomes.Keywords
This publication has 42 references indexed in Scilit:
- The impact of bariatric surgery on estimated glomerular filtration rate in patients with type 2 diabetes: a retrospective cohort studySurgery for Obesity and Related Diseases, 2016
- Determinants of Evolution of Glomerular Filtration Rate After Bariatric Surgery: a 1-Year Observational StudyObesity Surgery, 2016
- Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesisNature Reviews Nephrology, 2016
- Does bariatric surgery really prevent deterioration of renal function?Surgery for Obesity and Related Diseases, 2016
- Effect of weight loss after bariatric surgery on kidney function in a multiethnic Asian populationSurgery for Obesity and Related Diseases, 2016
- The risk of kidney stones following bariatric surgery: a systematic review and meta-analysisRenal Failure, 2016
- The effect of bariatric surgery on renal functionSurgery for Obesity and Related Diseases, 2014
- Bariatric surgery-induced weight loss: Does it have any impact on serum cystatin C levels?Surgery for Obesity and Related Diseases, 2014
- The effect of bariatric surgery on renal function and disease: a focus on outcomes and inflammationNephrology Dialysis Transplantation, 2013
- Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective studySurgery for Obesity and Related Diseases, 2013